The Need: Accessing the pericardium is currently a dangerous process. The current technology uses a needle pointed directly towards the heart, posing a risk of puncturing and damaging the heart (mostly the Right Ventricle), lungs, Liver and Diaphragma.
 

The Solution: CardioVia is developing a safer alternative, one that does not point a needle towards the heart. With safer, easier, and more efficient pericardial access, the pericardial space can be used for treating a wide variety of heart conditions and one of these ways of treatment within the space can be drug delivery based.